EMD-22853

Single-particle
3.8 Å
EMD-22853
3D View Gallery
Deposition: 13/10/2020
Map released: 28/04/2021
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-22853
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7kfh summary report (pdf.gz) Map and 7kfh FULL report (pdf.gz)
EMICSS annotations (xml)

Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-437 and EBOV-515

EMD-22853

Single-particle
3.8 Å
EMD-22853
3D View Gallery
Deposition: 13/10/2020
Map released: 28/04/2021
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Ebola virus
Sample: Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-437 and EBOV-515
Fitted models: 7kfh

Deposition Authors: Murin CD, Ward AB
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies.
Murin CD, Gilchuk P, Ilinykh PA, Huang K , Kuzmina N, Shen X, Bruhn JF, Bryan AL, Davidson E, Doranz BJ, Williamson LE, Copps J, Alkutkar T, Flyak AI, Bukreyev A, Crowe Jr JE, Ward AB
(2021) Cell Rep , 35 , 108984 - 108984
PUBMED: 33852862
DOI: doi:10.1016/j.celrep.2021.108984
ISSN: 2211-1247